References
- Sullivan PW, Salmon SE: Kinetics of tumor growth and regression in IgG multiple myeloma. J Clin Invest 51: 1697–1708, 1972
- Salmon SE: Immunoglobulin synthesis and tumor kinetics of multiple myeloma. Semin Hematol 10: 135–144, Apr 1973
- Bergsagel DE: Plasma cell myeloma: An interpretive review. Cancer 30: 1588–1594, 1972
- Dune BG, Salmon SE: A clinical staging system for multiple myeloma. Cancer 36: 842–854, 1975
- Alexanian R, et al: Unmaintained remissions in multiple myeloma. In M. D. Anderson Hospital and Tumor Institute: Cancer Chemotherapy: Fundamental Concepts and Recent Advances. Chicago, Year Book Medical Publishers, Inc, 1975, pp 155–171
- Alexanian R, Balcerzak S, Haut EA, et al: Remission maintenance therapy for multiple myeloma. Arch Intern Med 135: 147–152, 1975
Bibliography
- Alexanian R: Plasma cell neoplasms. Cancer 26: 38–48, 1976
- Alexanian R, Bonnet J, Gehan E, et al: Combination chemotherapy for multiple myeloma. Cancer 30: 382–389, 1972
- Costa G, Eng le RL Jr, Schilling A, et al: Melphalan and prednisone: An effective combination for the treatment of multiple myeloma. Am J Med 54: 589–599, 1973
- Kyle RA, Elveback LR: Management and prognosis of multiple myeloma. Mayo Clin Proc 51: 751–760, 1976
- Salmon SE, Smith BA: Immunoglobulin synthesis and total body tumor cell number in IgG multiple myeloma. J Clin Invest 49: 1114–1121, 1970
- Zawadzki Z: Clinical significance of monoclonal immunoglobulinemia. Bull Rheum Dis 25: 810–814, 1975